Allelic deletions of chromosome 18q are reported to be common in prostate and colorectal cancers, suggesting that one or more tumor suppressor genes on 18q are involved in the genesis of these neoplasms. The DPC4 gene, a recently identified candidate tumor suppressor in 18q21, was examined for evidence of inactivation in prostatic carcinomas, and results compared to those of a parallel analysis of colorectal carcinomas, for which DPC4 mutation has been reported in ∼10% of cases. In this study, only three (10%) of 29 informative primary prostate cancers showed allelic loss of chromosome 18q21 markers, and no point mutations or deletions of DPC4 were detected in the complete set of 45 primary or metastatic cases. In contrast, five (56%) of nine primary colorectal tumors displayed allelic loss of 18q markers and in one of these a somatically acquired G→T missense mutation was found in exon 1. Of twelve colorectal tumor cell lines, one showed a G→C missense mutation in exon 8 and two had partial homozygous deletions that would likely abrogate gene function. These data suggest that DPC4 is rarely if ever mutated during prostatic oncogenesis, whereas inactivation of this gene may contribute to the genesis of a subset of colorectal carcinomas.
Your institute does not have access to this article
Open Access articles citing this article.
BMC Cancer Open Access 05 April 2014
British Journal of Cancer Open Access 28 March 2013
Tumor suppressor FLCN inhibits tumorigenesis of a FLCN-null renal cancer cell line and regulates expression of key molecules in TGF-β signaling
Molecular Cancer Open Access 23 June 2010
Subscribe to Journal
Get full journal access for 1 year
only $2.38 per issue
All prices are NET prices.
VAT will be added later in the checkout.
Tax calculation will be finalised during checkout.
Get time limited or full article access on ReadCube.
All prices are NET prices.
About this article
Cite this article
MacGrogan, D., Pegram, M., Slamon, D. et al. Comparative mutational analysis of DPC4 (Smad4) in prostatic and colorectal carcinomas. Oncogene 15, 1111–1114 (1997). https://doi.org/10.1038/sj.onc.1201232
- tumor suppressor gene
- prostate cancer
- colorectal cancer
Bromodomain and extra-terminal motif (BET) inhibition is synthetic lethal with loss of SMAD4 in colorectal cancer cells via restoring the loss of MYC repression
SMAD2 rs4940086 heterozygosity increases the risk of cervical cancer development among the women in Bangladesh
Molecular Biology Reports (2020)
BMC Cancer (2014)
Role of SMAD4 in the mechanism of valproic acid’s inhibitory effect on prostate cancer cell invasiveness
International Urology and Nephrology (2014)
Tumor Biology (2014)